Literature DB >> 1599054

Disruption of Plasmodium falciparum erythrocyte rosettes by standard heparin and heparin devoid of anticoagulant activity.

J Carlson1, H P Ekre, H Helmby, J Gysin, B M Greenwood, M Wahlgren.   

Abstract

We have studied the ability of heparin to disrupt spontaneous rosettes formed between Plasmodium falciparum-infected and uninfected red blood cells, which has been proposed to have importance in the pathogenesis of cerebral malaria. Substantial variation in this activity was found among six laboratory stains of P. falciparum. Rosettes formed by three of these strains were highly sensitive to heparin (50% disruption at 0.5-25 micrograms/ml; 1 microgram/ml corresponds to 0.15 IU/ml). The rosettes formed by two other strains showed a much lower sensitivity (50% disruption at 700-2,500 micrograms/ml), while the rosettes formed by another strain were almost completely resistant to heparin (20% disruption at 6,500 micrograms/ml). The ability of heparin (65 or 650 micrograms/ml) to disrupt rosettes formed by 54 fresh Gambian isolates of P. falciparum also varied. Rosettes of 27 (50%) of the 54 isolates were disrupted to a significant degree (greater than or equal to 15%), while rosettes of the other 27 isolates remained unaffected at the concentrations tested. Heparin was fractionated by molecular weight and/or affinity for antithrombin III. We found that its property of rosette disruption was associated, to some extent, with size (high molecular weight) but not with its anticoagulant potential (affinity for antithrombin III). A heparin fraction with low affinity for antithrombin III and one with combined high molecular weight and low affinity for antithrombin III were as effective at disrupting rosettes as standard heparin, while a chemically modified (N-acetylated) high molecular weight-heparin fraction, similarly devoid of anticoagulant activity, lacked strong anti-rosette potential.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1599054     DOI: 10.4269/ajtmh.1992.46.595

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  37 in total

1.  Seaweeds as a source of lead compounds for the development of new antiplasmodial drugs from South East coast of India.

Authors:  Sundaram Ravikumar; Samuel Jacob Inbaneson; Palavesam Suganthi
Journal:  Parasitol Res       Date:  2010-12-29       Impact factor: 2.289

2.  Regioselectively modified sulfated cellulose as prospective drug for treatment of malaria tropica.

Authors:  Reinhard Schwartz-Albiez; Yvonne Adams; Claus-W von der Lieth; Petra Mischnick; Katherine T Andrews; Michael Kirschfink
Journal:  Glycoconj J       Date:  2007-01       Impact factor: 2.916

3.  Inhibition of Plasmodium falciparum growth in vitro and adhesion to chondroitin-4-sulfate by the heparan sulfate mimetic PI-88 and other sulfated oligosaccharides.

Authors:  Yvonne Adams; Craig Freeman; Reinhard Schwartz-Albiez; Vito Ferro; Christopher R Parish; Katherine T Andrews
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

4.  Low anticoagulant heparin disrupts Plasmodium falciparum rosettes in fresh clinical isolates.

Authors:  Anna M Leitgeb; Karin Blomqvist; Fidelis Cho-Ngwa; Moses Samje; Peter Nde; Vincent Titanji; Mats Wahlgren
Journal:  Am J Trop Med Hyg       Date:  2011-03       Impact factor: 2.345

Review 5.  Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies.

Authors:  Miloni Thakkar; Brijesh S
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

6.  In vitro antiplasmodial activity of ethanolic extracts of seaweed macroalgae against Plasmodium falciparum.

Authors:  Sundaram Ravikumar; Samuel Jacob Inbaneson; Palavesam Suganthi; Ramasamy Gokulakrishnan; Malaiyandi Venkatesan
Journal:  Parasitol Res       Date:  2010-12-01       Impact factor: 2.289

7.  In vitro inhibition of Plasmodium falciparum rosette formation by Curdlan sulfate.

Authors:  Helen M Kyriacou; Katie E Steen; Ahmed Raza; Monica Arman; George Warimwe; Peter C Bull; Ivan Havlik; J Alexandra Rowe
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

8.  Heparan sulphate identified on human erythrocytes: a Plasmodium falciparum receptor.

Authors:  Anna M Vogt; Gerhard Winter; Mats Wahlgren; Dorothe Spillmann
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

9.  High throughput functional assays of the variant antigen PfEMP1 reveal a single domain in the 3D7 Plasmodium falciparum genome that binds ICAM1 with high affinity and is targeted by naturally acquired neutralizing antibodies.

Authors:  Andrew V Oleinikov; Emily Amos; Isaac Tyler Frye; Eddie Rossnagle; Theonest K Mutabingwa; Michal Fried; Patrick E Duffy
Journal:  PLoS Pathog       Date:  2009-04-17       Impact factor: 6.823

Review 10.  Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications.

Authors:  J Alexandra Rowe; Antoine Claessens; Ruth A Corrigan; Mònica Arman
Journal:  Expert Rev Mol Med       Date:  2009-05-26       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.